Abstract
Context: Thyroid hormone (TH) mediated changes in gene expression were thought to be primarily
initiated by the nuclear TH receptor (TR) binding to a thyroid hormone response element
in the promoter of target genes. A recently described extranuclear mechanism of TH
action consists of the association of TH-liganded TRβ with phosphatidylinositol 3-kinase
(PI3K) in the cytosol and subsequent activation of the PI3K pathway.
Objective: The aim of this study was to examine the effect of TH, TRβ and PI3K on stanniocalcin
1 (STC1) expression in human cells.
Design: We treated human skin fibroblasts with triiodothyronine (T3) in the absence or presence
of the PI3K inhibitor LY294002, a dominant negative PI3K subunit, Δp85α, and the protein
synthesis inhibitor cycloheximide (CHX). The role of the TRβ was studied in cells
from patients with resistance to thyroid hormone (RTH). STC-1 mRNA expression was
measured by real-time PCR.
Results: We found an induction of STC1 by T3 in normal cells, but less in cells from subjects
with RTH (2.7±0.2 vs. 1.6±0.04, P<0.01). The effect of T3 was completely abrogated by blocking PI3K with LY294002 (3.9±0.5
vs. 0.85±0.5; P<0.05) and greatly reduced after transfection of a dominant negative PI3K subunit,
demonstrating dependency on the PI3K pathway.
Conclusion: These results establish STC1 as a TH target gene in humans. Furthermore, we show
that STC1 induction by TH depends on both TRβ and PI3K activation.
Key words
nongenomic action - hypoxia inducible factor 1 - HIF-1
References
- 1
Cao X, Kambe F, Moeller LC. et al .
Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target
of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
Mol Endocrinol.
2005;
19
102-112
- 2
Chakraborty A, Brooks HL, Zhang P. et al .
Stanniocalcin-1 regulates endothelial gene expression and modulates trans-endothelial
migration of leukocytes.
Am J Physiol Renal Physiol.
2007;
292
895-904
- 3
Chang AC, Janosi J, Hulsbeek M. et al .
A novel human cDNA highly homologous to the fish hormone stanniocalcin.
Mol Cell Endocrinol.
1995;
112
241-247
- 4
Chang AC, Jellinek DA, Reddel RR.
Mammalian stanniocalcins and cancer.
Endocr Relat Cancer.
2003;
10
359-373
- 5
Cheng SY, Leonard JL, Davis PJ.
Molecular Aspects of Thyroid Hormone Actions.
Endocr Rev.
2010;
31
139-170
- 6
Davis FB, Mousa SA, O’Connor L. et al .
Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and
is initiated at the cell surface.
Circ Res.
2004;
94
1500-1506
- 7
Davis FB, Tang HY, Shih A. et al .
Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma
cells.
Cancer Res.
2006;
66
7270-7275
- 8
Filvaroff EH, Guillet S, Zlot C. et al .
Stanniocalcin 1 alters muscle and bone structure and function in transgenic mice.
Endocrinology.
2002;
143
3681-3690
- 9
Furuya F, Hanover JA, Cheng SY.
Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone
beta receptor.
Proc Natl Acad Sci USA.
2006;
103
1780-1785
- 10
Lal A, Peters H, St Croix B. et al .
Transcriptional response to hypoxia in human tumors.
J Natl Cancer Inst.
2001;
93
1337-1343
- 11
Law AY, Ching LY, Lai KP. et al .
Identification and characterization of the hypoxia-responsive element in human stanniocalcin-1
gene.
Mol Cell Endocrinol.
2010;
314
118-127
- 12
Lei J, Mariash CN, Ingbar DH.
3,3′,5-Triiodo-L-thyronine up-regulation of Na, K-ATPase activity and cell surface
expression in alveolar epithelial cells is Src kinase- and phosphoinositide 3-kinase-dependent.
J Biol Chem.
2004;
279
47589-47600
- 13
Livak KJS, Schmittgen TD.
Analysis of relative gene expression data using real-time quantitative PCR and the
2(-Delta Delta C(T)) Method.
Methods.
2001;
25
402-408
- 14
Madsen KL, Tavernini MM, Yachimec C. et al .
Stanniocalcin: a novel protein regulating calcium and phosphate transport across mammalian
intestine.
Am J Physiol.
1998;
274
G96-G102
- 15
McCudden CR, James KA, Hasilo C. et al .
Characterization of mammalian stanniocalcin receptors. Mitochondrial targeting of
ligand and receptor for regulation of cellular metabolism.
J Biol Chem.
2002;
277
45249-45258
- 16
Moeller LC, Cao X, Dumitrescu AM. et al .
Thyroid hormone mediated changes in gene expression can be initiated by cytosolic
action of the thyroid hormone receptor beta through the phosphatidylinositol 3-kinase
pathway.
Nucl Recept Signal.
2006;
4
e020
- 17
Moeller LC, Dumitrescu AM, Refetoff S.
Cytosolic action of thyroid hormone leads to induction of hypoxia-inducible factor-1alpha
and glycolytic genes.
Mol Endocrinol.
2005a;
19
2955-2963
- 18
Moeller LC, Dumitrescu AM, Walker RL. et al .
Thyroid hormone responsive genes in cultured human fibroblasts.
J Clin Endocrinol Metab..
2005b;
90
936-943
- 19
Murata Y, Ceccarelli P, Refetoff S. et al .
Thyroid hormone inhibits fibronectin synthesis by cultured human skin fibroblasts.
J Clin Endocrinol Metab.
1987;
64
334-339
- 20
Samuels HH, Stanley F, Casanova J.
Depletion of L-3,5,3–triiodothyronine and L-thyroxine in euthyroid calf serum for
use in cell culture studies of the action of thyroid hormone.
Endocrinology.
1979;
105
80-85
- 21
Sheikh-Hamad D, Bick R, Wu GY. et al .
Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance
to human heart failure.
Am J Physiol Heart Circ Physiol.
2003;
285
H442-H448
- 22
Ullah MS, Davies AJ, Halestrap AP.
The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia
through a HIF-1alpha-dependent mechanism.
J Biol Chem.
2006;
281
9030-9037
- 23
Wagner GFD, Dimattia GE.
The stanniocalcin family of proteins.
J Exp Zoolog A Comp Exp Biol.
2006;
305
769-780
- 24
Yen PM.
Physiological and molecular basis of thyroid hormone action.
Physiol Rev.
2001;
81
1097-1142
- 25
Yeung HY, Lai KP, Chan HY. et al .
Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer
cells.
Endocrinology.
2005;
146
4951-4960
Correspondence
L. C. Moeller
Department of Endocrinology
University of Duisburg-Essen
Hufelandstraße 55
45122 Essen
Germany
Phone: +49/201/723 2821
Fax: +49/201/723 5187
Email: lars.moeller@uni-due.de
